What is the recommended antibiotic treatment and dosing for bacterial conjunctivitis in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Bacterial Conjunctivitis in Adults

For mild to moderate bacterial conjunctivitis in adults, a 5-7 day course of broad-spectrum topical antibiotic is recommended, with no particular antibiotic showing clear superiority over others. 1, 2

First-Line Treatment Options

Topical Antibiotics (5-7 day course):

  • Fluoroquinolones:

    • Ofloxacin 0.3% - 1 drop in affected eye(s) every 4-6 hours 1
    • Moxifloxacin 0.5% - 1 drop in affected eye(s) 3 times daily 3
    • Levofloxacin 0.5% - 1 drop in affected eye(s) every 2 hours while awake for first 2 days, then every 4 hours for 3 more days 4
  • Aminoglycosides:

    • Gentamicin 0.3% - 1 drop in affected eye(s) every 4 hours 1
  • Other options:

    • Erythromycin 0.5% ointment - apply small amount (1/4 inch) to lower conjunctival sac 2-4 times daily 2
    • Polymyxin B-trimethoprim - 1 drop in affected eye(s) every 4 hours 3, 5

Azithromycin Option:

  • Azithromycin 1% - 1 drop in affected eye(s) twice daily (8-12 hours apart) for first 2 days, then once daily for 5 more days 6

Treatment Algorithm

  1. For mild bacterial conjunctivitis:

    • Select any broad-spectrum topical antibiotic listed above based on availability and cost
    • Instruct patient on proper administration technique
    • Continue for full 5-7 day course even if symptoms resolve earlier
  2. For moderate to severe bacterial conjunctivitis:

    • Consider obtaining conjunctival cultures before initiating treatment
    • Begin with a fluoroquinolone (ofloxacin, moxifloxacin, or levofloxacin)
    • Follow up in 2-3 days to assess response
    • If no improvement, consider changing antibiotic based on culture results
  3. For suspected MRSA conjunctivitis:

    • Consider obtaining cultures
    • May require compounded topical antibiotics such as vancomycin 1

Efficacy Considerations

Research shows that topical antibiotics provide faster clinical and microbiological resolution compared to placebo, particularly in the first 2-5 days of treatment 1. While bacterial conjunctivitis is often self-limiting in immunocompetent adults, treatment shortens the duration of symptoms and may reduce transmissibility 1, 2.

Comparative studies have shown:

  • Moxifloxacin 0.5% three times daily achieved faster resolution (81% at 48 hours) compared to polymyxin B-trimethoprim four times daily (44% at 48 hours) 3
  • Levofloxacin 0.5% showed superior microbial eradication rates (90%) compared to ofloxacin 0.3% (81%) 4

Follow-Up Recommendations

  • For mild cases: Follow-up only if symptoms persist beyond 3-4 days of treatment
  • For moderate to severe cases: Follow-up within 2-3 days to assess response
  • At follow-up visits, assess:
    • Resolution of symptoms
    • Visual acuity
    • Slit-lamp examination if available

Important Caveats

  1. Complete the full course of treatment to prevent recurrence and antibiotic resistance 6

  2. Special cases requiring systemic antibiotics:

    • Gonococcal conjunctivitis
    • Chlamydial conjunctivitis
    • Conjunctivitis with significant eyelid involvement
  3. Warning signs requiring urgent referral:

    • Corneal involvement
    • Severe pain
    • Vision loss
    • No improvement after 3-4 days of treatment
  4. Adjunctive measures:

    • Warm compresses for eyelid involvement
    • Good hand hygiene to prevent transmission
    • Avoid sharing towels/washcloths
  5. Return to work/school: Patients can typically return to work/school after 24 hours of antibiotic treatment if symptoms are improving 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.